Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
about
Whole-genome sequencing targets drug-resistant bacterial infectionsLearning from the past for TB drug discovery in the futureLipoamide Channel-Binding Sulfonamides Selectively Inhibit Mycobacterial Lipoamide DehydrogenasePhylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis.New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistanceMycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular CompoundsAn ancient riboswitch class in bacteria regulates purine biosynthesis and one-carbon metabolismEmerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome.Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.Metabolomic strategies for the identification of new enzyme functions and metabolic pathwayspara-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosisReplacing sulfa drugs with novel DHPS inhibitorsIdentification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation modelGenetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012Target-based screen against a periplasmic serine protease that regulates intrabacterial pH homeostasis in Mycobacterium tuberculosis.The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.UDP-N-acetylmuramic acid l-alanine ligase (MurC) inhibition in a tolC mutant Escherichia coli strain leads to cell deathMycobacterium tuberculosis metabolismThe molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.Opposing effects of target overexpression reveal drug mechanismsGenetic Approaches to Facilitate Antibacterial Drug Development.Effects of fluconazole on the metabolomic profile of Candida albicans.A Focused Screen Identifies Antifolates with Activity on Mycobacterium tuberculosis.Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights.QSAR based therapeutic management of M. tuberculosis.A Biotin Biosynthesis Gene Restricted to Helicobacter.Ipso-hydroxylation and subsequent fragmentation: a novel microbial strategy to eliminate sulfonamide antibiotics.N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic AcidTargeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates.Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.The antimicrobial activity of nanoparticles: present situation and prospects for the futureCharacterizing the pocketome of Mycobacterium tuberculosis and application in rationalizing polypharmacological target selection.Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.Deletion of sigB Causes Increased Sensitivity to para-Aminosalicylic Acid and Sulfamethoxazole in Mycobacterium tuberculosis.Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.Antibiotic resistance mechanisms in M. tuberculosis: an update.Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.Anti-folates potentiate bactericidal effects of other antimicrobial agents.
P2860
Q26799059-453D583F-C6E7-4532-ACDA-56C1CF4D5C88Q27485405-7A3DFCBE-5CEF-4EDA-B53C-0C1A03FD8FA7Q27680644-53010483-B815-402C-992D-CF892A4B37E8Q27687284-29FE3A4F-DA0D-47F8-A768-C4CA681BD01EQ27902272-1097BB5E-15A3-4C6F-8C60-72BCD04C994BQ28082718-265BE754-ADC8-43DE-9EBA-801EF709A868Q28550069-0B681360-5EF9-407F-8F9A-BF1813B0C302Q28610747-579E5B7A-DBE2-4061-B5EA-DC6B6CBD554BQ30236042-CAFC498B-C80B-4374-9CCC-6EDB9AA24848Q30373724-262454B2-1572-44B1-8292-7DD78C898B30Q34342551-F1175BCE-51D6-4854-BEB3-3799523934E6Q34351796-7FF6812F-6574-437D-BE32-E9923CD27DA2Q34823402-0A2589B0-B839-47E1-9C32-D8489D838F74Q34881104-185BAF80-B393-4D82-B4BC-C875ED8EF393Q35105829-A99C91D9-1355-4B01-BB09-A27CE87B9A58Q35121081-F90DBC29-FF02-474D-A02F-0520739FBFE1Q35125060-F2B8588D-2597-43D5-8C5A-B4AB33258999Q35223217-BA97AF0B-6ECC-4B83-AB6B-EF9BAD1286B0Q35245286-2E901501-B174-4F71-B49C-03893790FA2FQ35513977-05DA1275-7AC5-4FCE-8170-F9301FE53FB1Q35535319-FC84DF16-9B75-43B5-9C0F-CDA3D6F65117Q35795582-14FF2F9A-C59A-4856-99AB-B1F01A92FBF3Q35868887-3BC2A060-9CE0-421F-A4F1-A69A732AD378Q35894966-7D89D4BB-67A9-4A44-8FC3-5624749BC67FQ35923699-EF764B28-140B-4F87-8252-7C3F04F0770FQ36359056-D0B32C67-466C-4710-B807-0CA6ECC496F8Q36574275-F23A90E8-9EA5-4C49-B759-9BDD8EFAB36AQ37123673-9AA0BB7B-CC15-4D35-9427-191DDA22C3DEQ37161540-61042BFE-D6BE-459B-A569-1BD94E79BA8AQ37428742-0854D5A8-0924-45FA-9488-D1F7B9E2CFCAQ37460655-B56BB2DB-0EF3-4D0E-A603-2086C01EF519Q37643668-6C609CA3-9582-4BB5-8E45-E62BE8D2E1B9Q37652887-55FE4406-ED23-474E-834B-5462F0DDDB44Q37733252-A1D15368-71AE-4AE4-8220-621D8A9223C1Q38258834-A16224A6-4E6D-4CE6-83F1-84FA1B1AC143Q38674795-9FE4920A-C296-4B7B-BBA6-E053E001B864Q38792855-DD4253C5-8AA4-4035-9721-589DD47F0F15Q38830420-5A0D0CFA-D0F5-4D95-BB15-C8C350DA587BQ39015804-89E67771-7894-4C2C-ABD6-8D88955638DCQ39028198-9617C5B1-FA18-4E86-A178-0AD94C93E3E6
P2860
Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@en
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@nl
type
label
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@en
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@nl
prefLabel
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@en
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@nl
P2093
P2860
P921
P356
P1433
P1476
Para-aminosalicylic acid acts ...... in Mycobacterium tuberculosis.
@en
P2093
Helena I Boshoff
Kyu Y Rhee
Sumit Chakraborty
Todd Gruber
P2860
P356
10.1126/SCIENCE.1228980
P407
P577
2012-11-01T00:00:00Z